These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23390045)

  • 1. Oromandibular dystonia associated with SCA36.
    Miyashiro A; Sugihara K; Kawarai T; Miyamoto R; Izumi Y; Morino H; Maruyama H; Orlacchio A; Kawakami H; Kaji R
    Mov Disord; 2013 Apr; 28(4):558-9. PubMed ID: 23390045
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.
    Yoshida K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral appliances in the treatment of oromandibular dystonia: a systematic review.
    De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P
    Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.
    Yoshida K
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block.
    Bianchini E; Massimiani A; Bemporad J; Giovannelli M
    Acta Neurol Belg; 2024 Jun; 124(3):1095-1097. PubMed ID: 38133850
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of abductor hallucis focal dystonia with botulinum toxin injection: a case presentation.
    Rosenberg NS; Odderson IR
    PM R; 2013 Aug; 5(8):726-8. PubMed ID: 23953019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulin A toxin: a highly effective drug in the treatment of focal dystonia].
    Timerbaeva SL; Ivanova-Smolenskaia IA; Markova ED; Poleshchuk VV; Karapetian MV; Rebrova OIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):32-5. PubMed ID: 10849964
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum Toxin, a Drug with Potential Interest for Dentists-An Introduction.
    Bakke M
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated lingual dystonia induced by speaking: a rare form of focal dystonia.
    Degirmenci Y; Ors CH; Yilmaz Y; Karaman HI
    Acta Neurol Belg; 2011 Dec; 111(4):360-1. PubMed ID: 22368983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias.
    Lungu C; Ahmad OF
    Semin Neurol; 2016 Feb; 36(1):41-6. PubMed ID: 26866495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial focal dystonia.
    Jiménez-Jiménez F; Martínez-Castrillo JC; Barón-Rubio M; Zurdo JM; de Toledo-Heras M; Vidal L; Hoenicka J
    Eur Neurol; 2002; 48(4):232-4. PubMed ID: 12422077
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.